David B. Roberts - 05 Feb 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: President and Director, Director
Issuer ticker: LMAT
Reported as of: 05 Feb 2026
Net transaction value: +$99,979
SEC form: 4
Accepted by SEC: 06 Feb 2026, 16:48:58 UTC
Prior SEC filing: 15 Dec 2025
Next SEC filing: 02 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

David B. Roberts filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 06 Feb 2026.

Key facts

This page summarizes David B. Roberts's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Feb 2026, 16:48.

Change

Previous filing in this sequence was filed on 15 Dec 2025.
Current net transaction value: +$99,979.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001365731 Primary reporting owner

Roberts David B

Relationship: President and Director, Director
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 06 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Options Exercise

Transaction value: $99,639
Shares: +2,672
Change %: +12%
Price: $37.29
Shares after: 24,923
Date: 05 Feb 2026
Ownership: Direct
Footnotes: F1

LMAT transaction

Common Stock

Options Exercise

Transaction value: $340
Shares: +7
Change %: +0.03%
Price: $48.60
Shares after: 24,930
Date: 05 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,672
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,672
Exercise price: $37.29
Footnotes: F2

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7
Change %: -0.05%
Price: $0.000000
Shares after: 14,054
Date: 05 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7
Exercise price: $48.60
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Footnote F2

This option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .